China, Oct. 27 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Phase I Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetic Characteristics of a Single Dose of QR052107B Tablets in Healthy Adult Volunteers'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135172
Registration Time: 2026/10/26
Type: Interventional study
Primary Sponsor: The Second Hospital of Anhui Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=325095
Published by HT Digital Content Services with permission from Health Daily Digest....